|
1
|
Kelly A, Blair N and Pechacek TF: Women
and smoking: Issues and opportunities. J Womens Health Gend Based
Med. 10:515–518. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dela Cruz CS, Tanoue LT and Matthay RA:
Lung cancer: Epidemiology, etiology, and prevention. Clin Chest
Med. 32:605–644. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakashita S, Sakashita M and Sound Tsao M:
Genes and pathology of non-small cell lung carcinoma. Semin Oncol.
41:28–39. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wakelee HA, Chang ET, Gomez SL, Keegan TH,
Feskanich D, Clarke CA, Holmberg L, Yong LC, Kolonel LN, Gould MK,
et al: Lung cancer incidence in never smokers. J Clin Oncol.
25:472–478. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yano T, Haro A, Shikada Y, Maruyama R and
Maehara Y: Non-small cell lung cancer in never smokers as a
representative 'non-smoking-associated lung cancer': Epidemiology
and clinical features. Int J Clin Oncol. 16:287–293. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Robinson JD and Cinciripini PM: The
effects of stress and smoking on catecholaminergic and
cardiovascular response. Behav Med. 32:13–18. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Timmermans W, Xiong H, Hoogenraad CC and
Krugers HJ: Stress and excitatory synapses: From health to disease.
Neuroscience. 248:626–636. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cole SW and Sood AK: Molecular pathways:
Beta-adrenergic signaling in cancer. Clin Cancer Res. 18:1201–1206.
2012. View Article : Google Scholar :
|
|
9
|
Schuller HM and Al-Wadei HAN:
Neurotransmitter receptors as central regulators of pancreatic
cancer. Future Oncol. 6:221–228. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Audet M and Bouvier M: Insights into
signaling from the beta2-adrenergic receptor structure. Nat Chem
Biol. 4:397–403. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Laag E, Majidi M, Cekanova M, Masi T,
Takahashi T and Schuller HM: NNK activates ERK1/2 and CREB/ATF-1
via beta-1-AR and EGFR signaling in human lung adenocarcinoma and
small airway epithelial cells. Int J Cancer. 119:1547–1552. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schuller HM and Cekanova M: NNK-induced
hamster lung adenocarcinomas over-express beta2-adrenergic and EGFR
signaling pathways. Lung Cancer. 49:35–45. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang W, Xu C, Tu H, Wang Y, Sun Q, Hu P,
Hu Y, Rondard P and Liu J: GABAB receptor upregulates fragile X
mental retardation protein expression in neurons. Sci Rep.
5:104682015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Entschladen F, Drell TL IV, Lang K, Joseph
J and Zaenker KS: Tumour-cell migration, invasion, and metastasis:
Navigation by neurotransmitters. Lancet Oncol. 5:254–258. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Al-Wadei HA, Takahashi T and Schuller HM:
Caffeine stimulates the proliferation of human lung adenocarcinoma
cells and small airway epithelial cells via activation of PKA, CREB
and ERK1/2. Oncol Rep. 15:431–435. 2006.PubMed/NCBI
|
|
17
|
Palm D, Lang K, Niggemann B, Drell TL IV,
Masur K, Zaenker KS and Entschladen F: The norepinephrine-driven
metastasis development of PC-3 human prostate cancer cells in
BALB/c nude mice is inhibited by beta-blockers. Int J Cancer.
118:2744–2749. 2006. View Article : Google Scholar
|
|
18
|
Drell TL IV, Joseph J, Lang K, Niggemann
B, Zaenker KS and Entschladen F: Effects of neurotransmitters on
the chemokinesis and chemotaxis of MDA-MB-468 human breast
carcinoma cells. Breast Cancer Res Treat. 80:63–70. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sood AK, Bhatty R, Kamat AA, Landen CN,
Han L, Thaker PH, Li Y, Gershenson DM, Lutgendorf S and Cole SW:
Stress hormone-mediated invasion of ovarian cancer cells. Clin
Cancer Res. 12:369–375. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mersmann HJ: Overview of the effects of
beta-adrenergic receptor agonists on animal growth including
mechanisms of action. J Anim Sci. 76:160–172. 1998.PubMed/NCBI
|
|
21
|
Yuan A, Li Z, Li X, Yi S, Wang S, Cai Y
and Cao H: The mitogenic effectors of isoproterenol in human
hepatocellular carcinoma cells. Oncol Rep. 23:151–157. 2010.
|
|
22
|
Bevilacqua M, Norbiato G, Chebat E, Baldi
G, Bertora P, Regalia E, Colella G, Gennari L and Vago T: Changes
in alpha-1 and beta-2 adrenoceptor density in human hepatocellular
carcinoma. Cancer. 67:2543–2551. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kassahun WT, Guenl B, Ungemach FR, Jonas S
and Abraham G: Expression and functional coupling of liver
β2-adrenoceptors in the human hepatocellular carcinoma.
Pharmacology. 89:313–320. 2012. View Article : Google Scholar
|
|
24
|
Schuller HM, Tithof PK, Williams M and
Plummer H III: The tobacco-specific carcinogen
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic
agonist and stimulates DNA synthesis in lung adenocarcinoma via
beta-adrenergic receptor-mediated release of arachidonic acid.
Cancer Res. 59:4510–4515. 1999.PubMed/NCBI
|
|
25
|
Pradidarcheep W, Stallen J, Labruyère WT,
Dabhoiwala NF, Michel MC and Lamers WH: Lack of specificity of
commercially available antisera against muscarinergic and
adrenergic receptors. Naunyn Schmiedebergs Arch Pharmacol.
379:397–402. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Daly CJ and McGrath JC: Previously
unsuspected widespread cellular and tissue distribution of
β-adrenoceptors and its relevance to drug action. Trends Pharmacol
Sci. 32:219–226. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shenoy SK and Lefkowitz RJ:
β-arrestin-mediated receptor trafficking and signal transduction.
Trends Pharmacol Sci. 32:521–533. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun Y, McGarrigle D and Huang X-Y: When a
G protein-coupled receptor does not couple to a G protein. Mol
Biosyst. 3:849–854. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fingleton B: Matrix metalloproteinases:
Roles in cancer and metastasis. Front Biosci. 11:479–491. 2006.
View Article : Google Scholar
|
|
31
|
Curran S and Murray GI: Matrix
metalloproteinases: Molecular aspects of their roles in tumour
invasion and metastasis. Eur J Cancer. 36:1621–1630. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lutgendorf SK, Cole S, Costanzo E, Bradley
S, Coffin J, Jabbari S, Rainwater K, Ritchie JM, Yang M and Sood
AK: Stress-related mediators stimulate vascular endothelial growth
factor secretion by two ovarian cancer cell lines. Clin Cancer Res.
9:4514–4521. 2003.PubMed/NCBI
|
